Procter & GamblePGCOMMENTJan 26, 2016Stock price when the opinion was issued
As of Jun 08, 2026. Market Open.
Owns neither. Of the two, he'd prefer JNJ. Hesitant to put them in the same basket. With spinoff of healthcare, it's now much more into pharmaceuticals (doing very well) and medical devices. Valuation is not that demanding. Executing well.
PG is a consumer products company. Consumer is in some difficulty, and jury's out as to whether we've seen the worst of that dip.
These consumer stocks are facing inflation. Revenue growth has been low, 3% the last quarter. Margins remain strong, though. Never been cheaper. Pays a 3% dividend. He isn't that bullish on the consumer, but PG is defensive. A good time to buy now, but don't expect a huge return, like 5-10% share appreciation + dividend.
You really can’t go wrong with a big consumer discretionary like this. He would have no problems with owning this for long periods of time. The issue is that they have a lot of global sales and the US$ is stronger. There are issues showing up in some of the emerging markets. A classic story of headwinds overseas. Valuation has come down and it is trading at a 21X PE ratio.